Cosmos Health (NASDAQ:COSM) Releases Earnings Results, Misses Expectations By $0.05 EPS

Cosmos Health (NASDAQ:COSM) issued its earnings results on Wednesday. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05), FiscalAI reports. Cosmos Health had a negative return on equity of 43.96% and a negative net margin of 29.33%.The company had revenue of $17.93 million during the quarter, compared to analysts’ expectations of $21.67 million.

Cosmos Health Stock Down 10.2%

Shares of COSM opened at $0.26 on Friday. Cosmos Health has a 52 week low of $0.25 and a 52 week high of $1.32. The company has a quick ratio of 0.85, a current ratio of 1.00 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $13.36 million, a price-to-earnings ratio of -0.42 and a beta of 5.00. The stock’s 50-day moving average price is $0.33 and its 200-day moving average price is $0.45.

Institutional Trading of Cosmos Health

A number of hedge funds have recently modified their holdings of COSM. XTX Topco Ltd boosted its position in Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after purchasing an additional 34,117 shares in the last quarter. Citadel Advisors LLC boosted its position in Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after purchasing an additional 128,776 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in Cosmos Health by 260.5% during the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock worth $167,000 after purchasing an additional 241,775 shares in the last quarter. Hedge funds and other institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.